HEADER TRANSPEPTIDASE 09-JUL-03 1PYY TITLE DOUBLE MUTANT PBP2X T338A/M339F FROM STREPTOCOCCUS PNEUMONIAE STRAIN TITLE 2 R6 AT 2.4 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PENICILLIN-BINDING PROTEIN 2X; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PBP-2X, PBP2X; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 171101; SOURCE 4 STRAIN: R6; SOURCE 5 GENE: PBPX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: MC1061; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX KEYWDS PENICILLIN-BINDING PROTEIN, ANTIBIOTIC RESISTANCE, PEPTIDOGLYCAN KEYWDS 2 SYNTHESIS, CELL WALL, TRANSMEMBRANE, TRANSPEPTIDASE EXPDTA X-RAY DIFFRACTION AUTHOR L.CHESNEL,L.PERNOT,D.LEMAIRE,D.CHAMPELOVIER,J.CROIZE,O.DIDEBERG, AUTHOR 2 T.VERNET,A.ZAPUN REVDAT 8 16-AUG-23 1PYY 1 REMARK REVDAT 7 27-OCT-21 1PYY 1 SEQADV HETSYN REVDAT 6 29-JUL-20 1PYY 1 COMPND REMARK HET HETNAM REVDAT 6 2 1 HETSYN FORMUL LINK SITE REVDAT 6 3 1 ATOM REVDAT 5 13-JUL-11 1PYY 1 VERSN REVDAT 4 24-FEB-09 1PYY 1 VERSN REVDAT 3 11-NOV-03 1PYY 2 JRNL REVDAT 2 14-OCT-03 1PYY 1 JRNL REVDAT 1 30-SEP-03 1PYY 0 JRNL AUTH L.CHESNEL,L.PERNOT,D.LEMAIRE,D.CHAMPELOVIER,J.CROIZE, JRNL AUTH 2 O.DIDEBERG,T.VERNET,A.ZAPUN JRNL TITL THE STRUCTURAL MODIFICATIONS INDUCED BY THE M339F JRNL TITL 2 SUBSTITUTION IN PBP2X FROM STREPTOCOCCUS PNEUMONIAE FURTHER JRNL TITL 3 DECREASES THE SUSCEPTIBILITY TO BETA-LACTAMS OF RESISTANT JRNL TITL 4 STRAINS JRNL REF J.BIOL.CHEM. V. 278 44448 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12923202 JRNL DOI 10.1074/JBC.M305948200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.DESSEN,N.MOUZ,E.GORDON,J.HOPKINS,O.DIDEBERG REMARK 1 TITL CRYSTAL STRUCTURE OF PBP2X FROM A HIGHLY REMARK 1 TITL 2 PENICILLIN-RESISTANT STREPTOCOCCUS PNEUMONIAE CLINICAL REMARK 1 TITL 3 ISOLATE REMARK 1 REF J.BIOL.CHEM. V. 276 45106 2001 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.M107608200 REMARK 1 REFERENCE 2 REMARK 1 AUTH E.GORDON,N.MOUZ,E.DUEE,O.DIDEBERG REMARK 1 TITL THE CRYSTAL STRUCTURE OF THE PENICILLIN BINDING PROTEIN 2X REMARK 1 TITL 2 FROM STREPTOCOCCUS PNEUMONIAE AND ITS ACYL-ENZYME FORM: REMARK 1 TITL 3 IMPLICATION IN DRUG RESISTANCE REMARK 1 REF J.MOL.BIOL. V. 299 477 2000 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.2000.3740 REMARK 1 REFERENCE 3 REMARK 1 AUTH S.PARES,N.MOUZ,Y.PETILLOT,R.HAKENBECK,O.DIDEBERG REMARK 1 TITL X-RAY STRUCTURE OF STREPTOCOCCUS PNEUMONIAE PBP2X, A PRIMARY REMARK 1 TITL 2 PENICILLIN TARGET ENZYME REMARK 1 REF NAT.STRUCT.BIOL. V. 3 284 1996 REMARK 1 REFN ISSN 1072-8368 REMARK 2 REMARK 2 RESOLUTION. 2.42 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.42 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.69 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1610393.460 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 40275 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2014 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.42 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5327 REMARK 3 BIN R VALUE (WORKING SET) : 0.2830 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 277 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4642 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 241 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 10.49000 REMARK 3 B22 (A**2) : -2.04000 REMARK 3 B33 (A**2) : -8.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 8.58000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.770 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.160 ; 2.500 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.010 ; 2.500 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.380 ; 3.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 43.29 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : OSUCROSE.PARAM REMARK 3 PARAMETER FILE 5 : MPD_CNS.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : OSUCROSE.TOP REMARK 3 TOPOLOGY FILE 5 : MPD_CNS.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1PYY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUL-03. REMARK 100 THE DEPOSITION ID IS D_1000019709. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40275 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.420 REMARK 200 RESOLUTION RANGE LOW (A) : 31.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.42 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : 0.19800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1QME REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 6000, 100 MM SODIUM ACETATE, REMARK 280 200 MM AMMONIUM SULFATE, GLYCYL-GLYCYL-GLYCINE, N- REMARK 280 OCTANOYLSUCROSE, PH 4.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 281K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 64.11200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.37300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 64.11200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.37300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 49 REMARK 465 THR A 50 REMARK 465 GLY A 51 REMARK 465 THR A 52 REMARK 465 ARG A 53 REMARK 465 PHE A 54 REMARK 465 GLY A 55 REMARK 465 THR A 56 REMARK 465 ASP A 57 REMARK 465 LEU A 58 REMARK 465 ALA A 59 REMARK 465 LYS A 60 REMARK 465 GLU A 61 REMARK 465 ALA A 62 REMARK 465 LYS A 63 REMARK 465 LYS A 64 REMARK 465 VAL A 65 REMARK 465 HIS A 66 REMARK 465 GLN A 67 REMARK 465 THR A 68 REMARK 465 THR A 69 REMARK 465 ARG A 70 REMARK 465 THR A 71 REMARK 465 VAL A 72 REMARK 465 VAL A 99 REMARK 465 ILE A 100 REMARK 465 ASP A 101 REMARK 465 GLU A 102 REMARK 465 ASN A 103 REMARK 465 TYR A 104 REMARK 465 LYS A 105 REMARK 465 SER A 106 REMARK 465 ALA A 107 REMARK 465 THR A 108 REMARK 465 GLY A 109 REMARK 465 LYS A 110 REMARK 465 ILE A 111 REMARK 465 LEU A 112 REMARK 465 TYR A 113 REMARK 465 VAL A 114 REMARK 465 GLU A 115 REMARK 465 LYS A 116 REMARK 465 THR A 117 REMARK 465 GLN A 118 REMARK 465 PHE A 119 REMARK 465 SER A 142 REMARK 465 GLN A 143 REMARK 465 PRO A 144 REMARK 465 ASN A 145 REMARK 465 LEU A 146 REMARK 465 LYS A 147 REMARK 465 GLN A 148 REMARK 465 SER A 165 REMARK 465 ILE A 166 REMARK 465 LYS A 167 REMARK 465 LYS A 168 REMARK 465 GLU A 169 REMARK 465 LEU A 170 REMARK 465 GLU A 171 REMARK 465 ALA A 172 REMARK 465 ALA A 173 REMARK 465 GLU A 174 REMARK 465 VAL A 175 REMARK 465 LYS A 176 REMARK 465 GLY A 177 REMARK 465 ILE A 178 REMARK 465 ASP A 179 REMARK 465 PHE A 180 REMARK 465 THR A 181 REMARK 465 THR A 182 REMARK 465 GLY A 232 REMARK 465 ILE A 233 REMARK 465 ILE A 234 REMARK 465 THR A 235 REMARK 465 TYR A 236 REMARK 465 GLU A 237 REMARK 465 LYS A 238 REMARK 465 ASP A 239 REMARK 465 ARG A 240 REMARK 465 LEU A 241 REMARK 465 GLY A 242 REMARK 465 ASN A 243 REMARK 465 ILE A 244 REMARK 465 VAL A 245 REMARK 465 PRO A 246 REMARK 465 GLY A 247 REMARK 465 THR A 248 REMARK 465 GLU A 249 REMARK 465 GLN A 250 REMARK 465 VAL A 251 REMARK 465 SER A 252 REMARK 465 GLN A 253 REMARK 465 ARG A 254 REMARK 465 THR A 255 REMARK 465 MET A 256 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 94 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 73 CA - N - CD ANGL. DEV. = -19.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 130 4.72 -153.82 REMARK 500 ASP A 131 14.76 53.65 REMARK 500 ARG A 138 -72.41 -60.63 REMARK 500 GLN A 140 -5.03 -56.32 REMARK 500 ALA A 161 -71.59 -61.54 REMARK 500 MET A 163 44.39 -79.89 REMARK 500 LYS A 315 15.38 56.55 REMARK 500 GLU A 363 138.68 -37.94 REMARK 500 ASP A 368 -5.63 75.58 REMARK 500 ASP A 488 24.77 -163.26 REMARK 500 LYS A 547 113.96 -162.58 REMARK 500 ASN A 558 53.61 -150.07 REMARK 500 ASN A 580 86.97 -150.66 REMARK 500 MET A 614 33.59 -96.73 REMARK 500 PRO A 639 172.10 -57.18 REMARK 500 ASN A 671 167.20 178.62 REMARK 500 ASN A 735 -7.17 79.54 REMARK 500 LYS A 742 -30.52 -130.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE OCTANOYL CHAIN IS BOUND TO THE FRUCTOSE REMARK 600 GROUP INSTEAD OF THE GLUCOSE GROUP. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QME RELATED DB: PDB REMARK 900 PENICILLIN-BINDING PROTEIN 2X (PBP-2X) REMARK 900 RELATED ID: 1QMF RELATED DB: PDB REMARK 900 PENICILLIN-BINDING PROTEIN 2X (PBP-2X): ACYL-ENZYME COMPLEX REMARK 900 RELATED ID: 1K25 RELATED DB: PDB REMARK 900 PBP2X FROM A HIGHLY PENICILLIN-RESISTANT STREPTOCOCCUS PNEUMONIAE REMARK 900 CLINICAL ISOLATE REMARK 900 RELATED ID: 1PMD RELATED DB: PDB REMARK 900 PENICILLIN-BINDING PROTEIN 2X (PBP-2X) DBREF 1PYY A 49 750 UNP P59676 PBPX_STRR6 49 750 SEQADV 1PYY ALA A 338 UNP P59676 THR 338 ENGINEERED MUTATION SEQADV 1PYY PHE A 339 UNP P59676 MET 339 ENGINEERED MUTATION SEQRES 1 A 702 GLY THR GLY THR ARG PHE GLY THR ASP LEU ALA LYS GLU SEQRES 2 A 702 ALA LYS LYS VAL HIS GLN THR THR ARG THR VAL PRO ALA SEQRES 3 A 702 LYS ARG GLY THR ILE TYR ASP ARG ASN GLY VAL PRO ILE SEQRES 4 A 702 ALA GLU ASP ALA THR SER TYR ASN VAL TYR ALA VAL ILE SEQRES 5 A 702 ASP GLU ASN TYR LYS SER ALA THR GLY LYS ILE LEU TYR SEQRES 6 A 702 VAL GLU LYS THR GLN PHE ASN LYS VAL ALA GLU VAL PHE SEQRES 7 A 702 HIS LYS TYR LEU ASP MET GLU GLU SER TYR VAL ARG GLU SEQRES 8 A 702 GLN LEU SER GLN PRO ASN LEU LYS GLN VAL SER PHE GLY SEQRES 9 A 702 ALA LYS GLY ASN GLY ILE THR TYR ALA ASN MET MET SER SEQRES 10 A 702 ILE LYS LYS GLU LEU GLU ALA ALA GLU VAL LYS GLY ILE SEQRES 11 A 702 ASP PHE THR THR SER PRO ASN ARG SER TYR PRO ASN GLY SEQRES 12 A 702 GLN PHE ALA SER SER PHE ILE GLY LEU ALA GLN LEU HIS SEQRES 13 A 702 GLU ASN GLU ASP GLY SER LYS SER LEU LEU GLY THR SER SEQRES 14 A 702 GLY MET GLU SER SER LEU ASN SER ILE LEU ALA GLY THR SEQRES 15 A 702 ASP GLY ILE ILE THR TYR GLU LYS ASP ARG LEU GLY ASN SEQRES 16 A 702 ILE VAL PRO GLY THR GLU GLN VAL SER GLN ARG THR MET SEQRES 17 A 702 ASP GLY LYS ASP VAL TYR THR THR ILE SER SER PRO LEU SEQRES 18 A 702 GLN SER PHE MET GLU THR GLN MET ASP ALA PHE GLN GLU SEQRES 19 A 702 LYS VAL LYS GLY LYS TYR MET THR ALA THR LEU VAL SER SEQRES 20 A 702 ALA LYS THR GLY GLU ILE LEU ALA THR THR GLN ARG PRO SEQRES 21 A 702 THR PHE ASP ALA ASP THR LYS GLU GLY ILE THR GLU ASP SEQRES 22 A 702 PHE VAL TRP ARG ASP ILE LEU TYR GLN SER ASN TYR GLU SEQRES 23 A 702 PRO GLY SER ALA PHE LYS VAL MET MET LEU ALA ALA ALA SEQRES 24 A 702 ILE ASP ASN ASN THR PHE PRO GLY GLY GLU VAL PHE ASN SEQRES 25 A 702 SER SER GLU LEU LYS ILE ALA ASP ALA THR ILE ARG ASP SEQRES 26 A 702 TRP ASP VAL ASN GLU GLY LEU THR GLY GLY ARG MET MET SEQRES 27 A 702 THR PHE SER GLN GLY PHE ALA HIS SER SER ASN VAL GLY SEQRES 28 A 702 MET THR LEU LEU GLU GLN LYS MET GLY ASP ALA THR TRP SEQRES 29 A 702 LEU ASP TYR LEU ASN ARG PHE LYS PHE GLY VAL PRO THR SEQRES 30 A 702 ARG PHE GLY LEU THR ASP GLU TYR ALA GLY GLN LEU PRO SEQRES 31 A 702 ALA ASP ASN ILE VAL ASN ILE ALA GLN SER SER PHE GLY SEQRES 32 A 702 GLN GLY ILE SER VAL THR GLN THR GLN MET ILE ARG ALA SEQRES 33 A 702 PHE THR ALA ILE ALA ASN ASP GLY VAL MET LEU GLU PRO SEQRES 34 A 702 LYS PHE ILE SER ALA ILE TYR ASP PRO ASN ASP GLN THR SEQRES 35 A 702 ALA ARG LYS SER GLN LYS GLU ILE VAL GLY ASN PRO VAL SEQRES 36 A 702 SER LYS ASP ALA ALA SER LEU THR ARG THR ASN MET VAL SEQRES 37 A 702 LEU VAL GLY THR ASP PRO VAL TYR GLY THR MET TYR ASN SEQRES 38 A 702 HIS SER THR GLY LYS PRO THR VAL THR VAL PRO GLY GLN SEQRES 39 A 702 ASN VAL ALA LEU LYS SER GLY THR ALA GLN ILE ALA ASP SEQRES 40 A 702 GLU LYS ASN GLY GLY TYR LEU VAL GLY LEU THR ASP TYR SEQRES 41 A 702 ILE PHE SER ALA VAL SER MET SER PRO ALA GLU ASN PRO SEQRES 42 A 702 ASP PHE ILE LEU TYR VAL THR VAL GLN GLN PRO GLU HIS SEQRES 43 A 702 TYR SER GLY ILE GLN LEU GLY GLU PHE ALA ASN PRO ILE SEQRES 44 A 702 LEU GLU ARG ALA SER ALA MET LYS ASP SER LEU ASN LEU SEQRES 45 A 702 GLN THR THR ALA LYS ALA LEU GLU GLN VAL SER GLN GLN SEQRES 46 A 702 SER PRO TYR PRO MET PRO SER VAL LYS ASP ILE SER PRO SEQRES 47 A 702 GLY ASP LEU ALA GLU GLU LEU ARG ARG ASN LEU VAL GLN SEQRES 48 A 702 PRO ILE VAL VAL GLY THR GLY THR LYS ILE LYS ASN SER SEQRES 49 A 702 SER ALA GLU GLU GLY LYS ASN LEU ALA PRO ASN GLN GLN SEQRES 50 A 702 VAL LEU ILE LEU SER ASP LYS ALA GLU GLU VAL PRO ASP SEQRES 51 A 702 MET TYR GLY TRP THR LYS GLU THR ALA GLU THR LEU ALA SEQRES 52 A 702 LYS TRP LEU ASN ILE GLU LEU GLU PHE GLN GLY SER GLY SEQRES 53 A 702 SER THR VAL GLN LYS GLN ASP VAL ARG ALA ASN THR ALA SEQRES 54 A 702 ILE LYS ASP ILE LYS LYS ILE THR LEU THR LEU GLY ASP HET GLC B 1 11 HET TRV B 2 21 HET SO4 A 751 5 HET MPD A 753 8 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM TRV 6-O-OCTANOYL-BETA-D-FRUCTOFURANOSE HETNAM SO4 SULFATE ION HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 GLC C6 H12 O6 FORMUL 2 TRV C14 H26 O7 FORMUL 3 SO4 O4 S 2- FORMUL 4 MPD C6 H14 O2 FORMUL 5 HOH *241(H2 O) HELIX 1 1 LYS A 121 LEU A 130 1 10 HELIX 2 2 GLU A 133 GLN A 140 1 8 HELIX 3 3 ALA A 194 GLY A 199 1 6 HELIX 4 4 SER A 217 LEU A 223 1 7 HELIX 5 5 LEU A 223 GLY A 229 1 7 HELIX 6 6 SER A 266 LYS A 285 1 20 HELIX 7 7 ASP A 326 SER A 331 1 6 HELIX 8 8 PRO A 335 ALA A 338 5 4 HELIX 9 9 PHE A 339 ASN A 350 1 12 HELIX 10 10 PHE A 388 HIS A 394 1 7 HELIX 11 11 SER A 396 GLY A 408 1 13 HELIX 12 12 GLY A 408 PHE A 419 1 12 HELIX 13 13 ASN A 441 SER A 448 1 8 HELIX 14 14 SER A 449 GLY A 451 5 3 HELIX 15 15 THR A 457 ASN A 470 1 14 HELIX 16 16 PRO A 486 GLN A 489 5 4 HELIX 17 17 SER A 504 ASP A 521 1 18 HELIX 18 18 SER A 596 MET A 614 1 19 HELIX 19 19 LYS A 615 ASN A 619 5 5 HELIX 20 20 SER A 645 ASN A 656 1 12 HELIX 21 21 THR A 703 LEU A 714 1 12 HELIX 22 22 ALA A 737 ILE A 741 5 5 SHEET 1 A 6 ARG A 186 SER A 187 0 SHEET 2 A 6 PRO A 86 ASP A 90 -1 N GLU A 89 O SER A 187 SHEET 3 A 6 ILE A 79 TYR A 80 -1 N ILE A 79 O ALA A 88 SHEET 4 A 6 ASP A 260 THR A 263 1 O THR A 263 N TYR A 80 SHEET 5 A 6 ILE A 480 ASP A 485 -1 O ALA A 482 N TYR A 262 SHEET 6 A 6 THR A 490 LYS A 493 -1 O THR A 490 N ASP A 485 SHEET 1 B 2 SER A 93 TYR A 94 0 SHEET 2 B 2 ILE A 158 THR A 159 -1 O ILE A 158 N TYR A 94 SHEET 1 C 2 ALA A 201 GLU A 205 0 SHEET 2 C 2 LYS A 211 GLY A 215 -1 O SER A 212 N HIS A 204 SHEET 1 D 5 ILE A 301 ARG A 307 0 SHEET 2 D 5 TYR A 288 SER A 295 -1 N LEU A 293 O ALA A 303 SHEET 3 D 5 PHE A 583 GLN A 590 -1 O ILE A 584 N VAL A 294 SHEET 4 D 5 TYR A 568 SER A 576 -1 N PHE A 570 O VAL A 589 SHEET 5 D 5 ALA A 545 GLN A 552 -1 N GLY A 549 O SER A 571 SHEET 1 E 2 VAL A 358 ASN A 360 0 SHEET 2 E 2 MET A 385 THR A 387 -1 O MET A 386 N PHE A 359 SHEET 1 F 2 LEU A 364 ILE A 366 0 SHEET 2 F 2 ALA A 369 ILE A 371 -1 O ILE A 371 N LEU A 364 SHEET 1 G 2 TRP A 374 ASP A 375 0 SHEET 2 G 2 GLY A 379 LEU A 380 -1 O GLY A 379 N ASP A 375 SHEET 1 H 2 MET A 474 LEU A 475 0 SHEET 2 H 2 ILE A 498 GLY A 500 -1 O VAL A 499 N MET A 474 SHEET 1 I 2 TYR A 528 ASN A 529 0 SHEET 2 I 2 LYS A 534 PRO A 535 -1 O LYS A 534 N ASN A 529 SHEET 1 J 3 GLN A 659 VAL A 663 0 SHEET 2 J 3 GLN A 685 SER A 690 1 O ILE A 688 N VAL A 663 SHEET 3 J 3 ILE A 669 SER A 672 -1 N ASN A 671 O LEU A 689 SHEET 1 K 3 GLU A 717 GLN A 721 0 SHEET 2 K 3 LYS A 743 GLY A 749 1 O LEU A 746 N GLU A 719 SHEET 3 K 3 THR A 726 GLN A 730 -1 N LYS A 729 O THR A 747 LINK C1 GLC B 1 O2 TRV B 2 1555 1555 1.46 CISPEP 1 ARG A 307 PRO A 308 0 -0.09 CISPEP 2 SER A 576 PRO A 577 0 -0.18 CRYST1 128.224 64.746 146.974 90.00 118.89 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007799 0.000000 0.004303 0.00000 SCALE2 0.000000 0.015445 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007771 0.00000